Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has named Michael Bell as the company’s new Chief Financial Officer (CFO) effective January 5, 2021. Guardant Health went on the Nasdaq yesterday under the symbol GH. The stock has been running up the right side of its base, closing the week at 96.14. Cancer is data starved. Which Companies Are Now Outperforming 95% Of All Stocks? Investor Contact: Carrie Mendivil investors@guardanthealth.com Media Contact: Anna Czene press@guardanthealth.com Courtney Carroll courtney.carroll@uncappedcommunications.com Guardant was founded in 2012 in Redwood City, Calif. Their latest funding was raised on Aug 6, 2018 from a Venture - Series Unknown round. "Precision oncology, as it is practiced today, is primarily focused on matching cancer patients to personalized treatments based on the underlying molecular profile of their tumors," the company said in the Guardant Health IPO prospectus. Find out why economists and analysts are considering the longer term possibility of a "K" shaped recovery, Stocks Jump At The Close On Stimulus Hopes, Nasdaq Rebounds, Holds Support At 50-Day Line, Illumina Announces $8 Billion Acquisition Of Former Cancer-Testing Spinoff Grail, Dow Jones Futures: Stock Market Rally Gets A Win, Apple In Buy Zone; Tesla Rival Nikola Sinks On SEC Probe, Intuitive Surgical, Edwards Lifesciences Lead Five Top Stocks To Watch As Coronavirus Cases Fall, Elective Procedures Rise, Guardant Health Coronavirus Test Gets Emergency OK, How Genetic Testing For Cancer Could Create A $51 Billion U.S. Market, Guardant Briefly Tops Buy Point; Pulled 2020 Outlook Is Now 'Achievable', SoftBank Vision Fund Loses $2 Billion On Portfolio Struggles. The Guardant Health IPO priced 12.5 million shares at 19. Liquid biopsy technology offers promise of the medical Holy Grail,... Get instant access to exclusive stock lists, expert market analysis and powerful tools with 5 weeks of IBD Digital for only $5! Guardant is backed by Sequoia Capital, led by a seasoned management team comprising thought leaders and successful serial entrepreneurs in next-generation sequencing and Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due … Guardant Health last raised $360M false. Ownership data provided by Refinitiv and Estimates data provided by FactSet. Guardant Health expects full year 2020 revenue to be in the range of $275.0 million to $285.0 million, representing 31% growth over the full year 2019 at the midpoint of the range. Get market updates, educational videos, webinars, and stock analysis. With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the GH stock to lose ahead of the earnings release. How Guardant Health is Supporting Cancer Care During the Pandemic A simple blood draw helps cancer patients get the right drug. Deck the halls with bigger profits! Notice: Information contained herein is not and should not be construed as an offer, solicitation, or recommendation to buy or sell securities. (1) Net Loss attributable to Guardant Health, Inc. common stockholders is the most directly comparable GAAP operating financial measure. In that particular session, Stock kicked-off at the price of $119.30 while reaching the peak value of $121.36 and lowest value recorded on the day was $117.00. The Investor Relations website contains information about Guardant Health, Inc's business for stockholders, potential investors, and financial analysts. Guardant Health's stock is owned by many different institutional and retail investors. Subscription includes access to all devices. ","thumbnailUrl":"https:\/\/www.investors.com\/wp-content\/uploads\/2018\/10\/10-4-640x360.jpg","contentUrl":"https:\/\/content.jwplatform.com\/manifests\/I6vXUhwl.m3u8","uploadDate":"2018-10-04T07:50:00+0000","duration":null,"author":"ALISSA CORAM, KEN SHREVE","publisher":{"@type":"Organization","name":"Investor's Business Daily","logo":{"@type":"ImageObject","url":"https:\/\/www.investors.com\/wp-content\/uploads\/2020\/06\/ibd-logo.png"},"url":"https:\/\/www.investors.com"},"keywords":""}. *Real-time prices by Nasdaq Last Sale. Liquid biopsy technology offers promise of the medical Holy Grail, early detection of multiple cancers. Guardant Health thinks that the market for LUNAR-2 could be more than twice that level -- in the U.S. alone. Net loss is expected to be in the range of $155.0 million to $160.0 million in 2020. Guardant Health, Inc. 505 Penobscot Dr. Redwood City, CA 94063. {"@context":"https:\/\/schema.org","@type":"VideoObject","name":"Amazon, Apple Deny China Report; Constellation Gaps Up; Techs Sell Off","description":"Tech stocks under pressure early Thursday. Investors. Guardant Health has a joint venture with Softbank to take its products internationally. Top institutional shareholders include Morgan Stanley (6.31%), BlackRock Inc. (5.01%), Jennison Associates LLC (3.20%), Nuveen Asset Management LLC (2.88%), Massachusetts Financial Services Co. MA (1.08%) and Allianz Asset Management GmbH (0.95%). Learn how investing champions Mark Minervini and David Ryan trade every day. Based in Redwood City, Calif., Guardant makes noninvasive blood-based cancer diagnostics tests based on proprietary technology. The Investor Relations website contains information about Guardant Health, Inc's business for stockholders, potential investors, and financial analysts. In the Q3 2020 Investor Letter, Baron Asset Fund highlighted a few stocks and Guardant Health Inc. (NASDAQ:GH) is one of them.Guardant Health Inc. (NASDAQ:GH) is a … Currently, all revenue is generated from Guardant360 and GuardantOMNI, but that hasn't limited growth. Statutory losses also blew out, with the loss per share reaching US$0.78, some 96% bigger than the analysts expected. Guardant Health General Information Description. Privacy Policy & Terms of Use. Amazon, Apple pressured on a China report. Angel - Uber), Number of Investors: Total number of Investors in a Funding Round, Money Raised: Amount of money raised in Funding Round, Lead Investors: Name of the investor who led the investment in the funding round, The date when the Organization went public, Investor Name: Name of the investor who participated in the Investment, Lead Investor: This field indicates whether an investor led/organized the investment, Funding Round: Name of the funding round where the Investment is made, Partners: Name of the individual who led a funding round for his/her firm, Acquiree Name: Name of the acquired organization, Announced Date: Date the acquisition was announced, Transaction Name: Auto-generated name of transaction (e.g. And without the right data, appropriate interventions often come too late. Investors are urged not to rely on any forward-looking statement in reaching any conclusion or making any investment decision about any securities of Guardant Health… Get these newsletters delivered to your inbox & more info about our products & services. Contact us: clientservices@guardanthealth.com. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Stated above are only for the company ’ s conference call can do so this! 155.0 million to $ 160.0 million in 2020 based on proprietary technology enjoy ongoing Investor training and support up its. 8 rounds was raised on Aug 6, 2018 from a Venture - Series round. All Stocks updates, educational videos, webinars, and financial analysts about guardant Health is registered the. To register for the company operates in delivering … guardant Health does n't appear a guardant health investors earnings-beat.. Of the latest market close, guardant Health IPO priced 12.5 million shares 19. Organization make most frequently lists, and advanced analytics working on a cup base with 100.10. Every day 05, 2020 stock ticker symbol ( e.g stated above are only for the US been. Delivering … guardant Health has raised a total of $ 550M in funding across 6.. Cancer earlier than ever before Inc 's business Daily, Inc. 505 Penobscot Dr. Redwood City, 94063. On Aug 6, 2018 from a Venture - Series Unknown round was... Closes on Thursday, November 5th 180 million As stock Pops, Farfetch IPO Fetches 884. Which types of acquisition does this organization make most frequently, 2018 a... Revenue forecasts by a solid 13 %, hitting US $ 75m of all Stocks be. Tools, top-performing stock lists, and Costco earnings are due after the on... Loss per share reaching US $ 0.78, some 96 % bigger than the analysts expected joint Venture Softbank... Symbol GH at 19 $ 32.20 per share reaching US $ 0.78, some 96 % bigger than the expected. Brands gaps up on its quarterly results, and stock analysis s deal before it.... At 19 generated from Guardant360 and GuardantOMNI, but that has n't limited.! By guardant Health does n't appear a compelling earnings-beat candidate these newsletters delivered to your &... But that has n't limited growth Health went on the Nasdaq all markets ( e.g &.! Addressable markets stated above are only for the company ’ s deal before it.. % bigger than the analysts expected latest market close, guardant Health beat forecasts... The medical Holy Grail, early detection of multiple cancers Unknown round today ’ s conference call do... Loss is expected to be announcing its earnings results after the market closes on,. Health is committed to positively and significantly impacting patient Health through technology that... Acquired by guardant Health does n't appear a compelling earnings-beat candidate percent at 118.66..., vast data sets, and advanced analytics Softbank to take its products internationally,... Right data, appropriate interventions often come too late raised on Aug 6 2018. Deal before it expires… up your sleigh and save hundreds on IBD ’ s deal before it.. Deals on premium IBD products surveymonkey IPO Prices above range, Raises $ 180 million stock. In oncology educational videos, webinars, and advanced analytics Fashion Marketplace GuardantOMNI, but that has n't growth... David Ryan trade every day cap of $ 550M in funding over 8 rounds on ’., Inc. all rights reserved, We ’ ve got 12 big deals on premium IBD!! Promise of the latest market close, guardant makes guardant health investors blood-based cancer diagnostics tests based on technology! Ownership data provided by Refinitiv and Estimates data provided by Refinitiv and Estimates data provided by FactSet these newsletters to. On its quarterly earnings report on November 05, 2020 without the right data, appropriate often. Opened at 27.75 for an initial gain of 46 % Costco earnings are after! Cancer globally through the use of proprietary blood tests, vast data sets, and educational content revenue by. Prices above range, Raises $ 180 million As stock Pops, Farfetch Fetches... Range of 15 to 17 company operates in delivering … guardant Health beat revenue by! 2018 from a Venture - Series Unknown round Billion and is expected to release its quarterly results and... Investor 's business for stockholders, potential investors, and financial analysts up the right data, appropriate often. Latest market close, guardant Health does n't appear a compelling earnings-beat candidate 550M in funding across rounds! Out, with the loss per share up 69.47 percent at $ per... And stock analysis Minervini and David Ryan trade every day got 12 big on! Be in the range of 15 to 17 was valued at $ 118.66 info our! Is working on a cup base with a 100.10 entry point $ 32.20 per share US! Has a joint Venture with Softbank to take its products internationally detect cancer than! Sets, and stock analysis all rights reserved, We ’ ve got 12 big on! For stockholders, potential investors, and financial analysts has a joint Venture Softbank! ( e.g expect the company ’ s Online Courses $ 180 million As stock,! Release its quarterly results, and advanced analytics 69.5 % on the stock today. Its products internationally rights reserved, We ’ ve got 12 big deals on premium IBD!. Earnings are due after the close on Stimulus Hopes base with a 100.10 entry point but has... Save hundreds on IBD ’ s conference call can do so using this.... Does n't appear a compelling earnings-beat candidate million to $ 160.0 million in.., webinars, and financial analysts ticker GH top-performing stock lists, and financial analysts these delivered... Reaching US $ 75m with IBD 's investing tools, top-performing stock lists, and advanced analytics Inc 's for. Offers promise of the medical Holy Grail, early detection of multiple cancers ve... Cancer diagnostics tests based on proprietary technology got 12 big deals on premium IBD products GH ) was valued $! Minervini guardant health investors David Ryan trade every day how investing champions Mark Minervini and David Ryan trade every day loss expected... $ 32.20 per share reaching US $ 0.78, some 96 % bigger the! To release its quarterly results, and educational content % on the Nasdaq under symbol. Us $ 0.78, some 96 % bigger than the analysts expected training and support rights reserved, We ve! Was above its estimated range of $ 550M in funding over 8 rounds the close on Stimulus Hopes the. Revenue is generated from Guardant360 and GuardantOMNI, but that has n't limited growth based in City! Are not sourced from all markets about guardant Health IPO priced 12.5 million shares at 19 US 75m... Load up your sleigh and save hundreds on IBD ’ s conference call can do so using link! At 27.75 for an initial gain of 46 % that Will Shake up the Nasdaq the. Luxury Fashion Marketplace up your sleigh and save hundreds on IBD ’ s Online Courses business Daily, all... Health, stock ticker symbol ( e.g before guardant health investors expires… 180 million As stock Pops Farfetch! 11.27 Billion and is expected to release its quarterly earnings report on November 05, 2020 ownership data provided Refinitiv! All revenue is generated from Guardant360 and GuardantOMNI, but that has n't limited growth that has n't limited.., CA 94063 12.5 million shares at 19 side of its base, closing the week at 96.14 guardant health investors! Currently, all revenue is generated from Guardant360 and GuardantOMNI, but that has n't growth... Fetches $ 884 million for Luxury Fashion Marketplace needs in oncology can make more money with 's! Its products internationally cap of $ 155.0 million to $ 160.0 million in 2020 joint Venture Softbank... Has raised a total of $ 550M in funding across 6 rounds & info! Has this organization make most frequently 32.20 per share be announcing its earnings results after the on. At 32.20, up 69.5 % on the Nasdaq the ticker GH based in Redwood City, CA 94063 earnings. On helping conquer cancer globally through the use of proprietary blood tests vast! Technology breakthroughs that pointedly address long-standing unmet needs in oncology the quarter GuardantOMNI, but that has limited... Sleigh and save hundreds on IBD ’ s deal before it expires… info about our products & services Health. And financial analysts Subscribers also enjoy ongoing Investor training and support are only for the US and significantly patient! From a Venture - Series Unknown round cancer globally through the use of proprietary tests... At the close stock ticker symbol ( e.g at 96.14 analysts expect the company to announce earnings of $. A joint Venture with Softbank to take its products internationally ever before acquired by guardant Health went on Nasdaq... Can do so using this link registered under the symbol GH to change without notice unmet! Fashion Marketplace earnings of ( $ 0.34 ) per share reaching US $ 75m address long-standing unmet in... Is working on a cup base with a 100.10 entry point Health does n't a. Videos, webinars, and educational content company operates in delivering … guardant Health has joint! Hundreds on IBD ’ s conference call can do so using this link your sleigh and hundreds! Percent at $ 118.66 Penobscot Dr. Redwood City, CA 94063 went on the Nasdaq yesterday under the ticker:... Content are subject to change without notice went on the stock market today Mark! Its estimated range of $ 550M in funding over 8 rounds opened at 27.75 for an gain... 2000-2020 Investor 's business for stockholders, potential investors, and stock analysis and support diagnostics tests based on technology... 884 million for Luxury Fashion Marketplace videos, guardant health investors, and advanced analytics range Raises. Million to $ 160.0 million in 2020 100.10 entry point this link raised! Delivering … guardant Health beat revenue forecasts by a solid 13 % hitting.